Tinostamustine is an investigational drug with a potential first-in-class mechanism combining bifunctional alkylating activity and pan histone deacetylase (HDAC) inhibition
Agreement enables access of EU-approved treatment for myotonia symptoms in non-dystrophic myotonic disorders to patients from Argentina and Colombia
With this additional route of administration, the MMRV Family now joins other routinely recommended vaccines that can be administered intramuscularly
NDM disorders are a group of rare, inherited neuromuscular disorders with an estimated prevalence of 1 case per 100,000 inhabitants in Spain, and are characterized by the inability to relax muscles following voluntary contraction (myotonia)
The new facility will be able to handle four times as many patients as the previous facility.
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
The company has unveiled the results of pirtobrutinib from its BRUIN CLL-313 study
Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
The fresh capital will propel Cordance into its first-in-human clinical trial
Deceased donor kidney transplants are time-critical, and it is uncommon to attempt them robotically
Subscribe To Our Newsletter & Stay Updated
